Effective polyclonal antibodies against the virulence-associated protein D (VapD) of Helicobacter pylori, obtained from recombinant VapD
Fig 7
Lane 1: mouse serum (5 µl) + bacterial lysate (20 µl); lane 2: mouse pre-immune serum (5 µl) + bacterial lysate (20 µl); lane 3: lysate of Rosetta (DE3) cells overexpressing rVapD (20 µl). MW, molecular weight.